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Protein–metabolite networks are central to biological systems, but are incompletely understood.
Here, we report a screen to catalog protein–lipid interactions in yeast. We used arrays of 56
metabolites to measure lipid-binding ﬁngerprints of 172 proteins, including 91 with predicted
lipid-binding domains. We identiﬁed 530 protein–lipid associations, the majority of which are
novel. To show the data set’s biological value, we studied further several novel interactions with
sphingolipids, a class of conserved bioactive lipids with an elusive mode of action. Integration
of live-cell imaging suggests new cellular targets for these molecules, including several with
pleckstrin homology (PH) domains. Validated interactions with Slm1, a regulator of actin polari-
zation, show that PH domains can have unexpected lipid-binding speciﬁcities and can act as
coincidence sensors for both phosphatidylinositol phosphates and phosphorylated sphingolipids.
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Introduction
Biological function emerges from the concerted action of
numerous interacting biomolecules. Deciphering the molecular
mechanisms behind cellular processes requires the systematic
charting of the multitude of interactions between all cellular
components. While protein–protein and protein–DNA networks
have been the subject of many systematic surveys, other
critically important cellular components, such as lipids, have
to date rarely been studied in large-scale interaction screens.
Lipids are one of the most abundant classes of cellular
metabolites, with a wide range of structural and functional
diversity. Their metabolism and transport account for about
5% of all coding genes in eukaryotes (van Meer, 2005). They
are essential building blocks of biological membranes and
some also function as anhydrous stores of energy. Besides
these house-keeping functions, growing numbers of lipids
are known to operate as signaling molecules, including
phosphatidylinositol phosphates (PtdInsPs) andsphingolipids.
Many of these functions, such as the recruitment of proteins to
the membrane via binding to PtdInsPs, are conserved from
yeast to human. Lipids are unevenly distributed among the
various cell membranes. Their correct partitioning relies on a
tight spatial organization of the enzymes involved in lipid
metabolism, which suggests extensive lipid–lipid and protein–
lipid interactions. The importance of these interactions is
evident from the variety of protein domains that have evolved
tobind particularlipids(Lemmon, 2008)andfromthe largelist
of disorders arising from altered protein–lipid interactions.
Human pathologies, such as cancer and bipolar disorder, have
been linked to mutations in genes involved in PtdInsPs
synthesis (Lee et al, 2007) or in domains specialized in their
recognition, such as the pleckstrin homology (PH) domain (Di
Paolo and De Camilli, 2006; Carpten et al, 2007). These
interactions are attractive targets for pharmaceutical drug
development. For instance, small molecule inhibitors of
phosphatidylinositide 3-kinases are currently in clinical trials
as anti-cancer drugs (Raynaud et al, 2007).
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comes from the study of a limited number of lipids, principally
PtdInsPs (Zhu et al, 2001), and lipid-binding domains (LBDs)
in isolation (Dowler et al, 2000; Yu and Lemmon, 2001; Yu
et al, 2004). For some signaling lipids, such as sphingolipids,
intracellular targets and molecular mechanisms are only
partially understood (Hannun and Obeid, 2008). The impor-
tance of lipids in biological processes and their under-
representation in current biological networks suggest the need
for systematic, unbiased biochemical screens (Dippold et al,
2009). Here, we describe the use of miniaturized arrays for the
study of protein–lipid interactions and report the lipid-binding
proﬁles for 172 soluble proteins. The screen successfully
recovers known protein–lipid-binding events and uncovers
many others not yet reported, several of which we validated
using a variety of other techniques. Many of the new
interactions promise to illuminate greatly the current under-
standing of lipids in signaling and other cell processes.
Results
Proﬁling of protein–lipid interactions in
Saccharomyces cerevisiae
To screen protein–lipid interactions, we adapted a lipid overlay
assay (Kanter et al, 2006) (Figure 1). We developed miniaturized
nitrocellulosearraysthatcontainedduplicatedsetsof51lipidsand
their metabolic intermediates that cover the main lipid classes in
yeast as deﬁned in the KEGG database of metabolic pathways
(Kanehisaetal,2008).F orcomparison,wealsoincludedﬁvenon-
physiological analogs that are not synthesized in yeast (Supple-
mentary Table S1A). We focused on the lipids that are exposed to
cytosolic proteins and excluded complex sphingolipids, such as
inositol phosphoceramide, mannosyl-inositolphosphoceramide
and mannosyl-diinositolphosphoceramide, which localize in the
extra-cellular leaﬂet of yeast membranes. We used the arrays to
determine the binding proﬁles of 172 soluble proteins, expressed
as carboxy-terminal tandem-afﬁnity-puriﬁcation (TAP)-tag fusion
proteins in S. cerevisiae (Gavin et al, 2006). Bound proteins were
immunodetected with an antibody that recognizes the TAP tag
(see Materials and methods; Supplementary information). The
selection included 91 proteins that were available from the
collection of TAP fusions and which contained one or several
possible LBDs as deﬁned by SMART (Letunic et al, 2006), Pfam
(Finnetal,2008)orSuperFamily(Goughetal,2 00 1).Thesetof9 1
covered 78% of all yeast proteins predicted or known to have an
LBD. We also selected 32 soluble lipid-regulated proteins and
enzymes involved in lipid metabolism, along with a set of
49 arbitrarily chosen soluble proteins (unclassiﬁed) (Figure 1;
Supplementary Table S1B).
We applied standardized protocols that gave an average
reproducibility of 74%, measured on the repeated analysis of
26 different TAP fusions (Supplementary Table S2). We also
expressed a subset of proteins in a heterologous system,
Escherichia coli (Figure 1), which provides additional evidence
for the interactions found in yeast. This also approximates the
fraction of the direct interactions, that is not mediated by
endogenous yeast proteins that will be absent in E. coli.
Importantly, as many mechanisms might account for failure to
recapitulate binding in E. coli (protein mis-folding or incorrect
post-translational modiﬁcations), reproducibility in E. coli
provides a lower limit for the fraction of direct interactions.
Bacterially expressed proteins recovered 58% of the associa-
tions initially observed with TAP fusions produced in yeast
(P 0.000001; Supplementary Table S2). Assuming that the
assay reproducibility is the same in yeast and E. coli, this
suggests that a minimum of 78% (58%/74%) of the total
observed interactions in yeast are direct.
We captured interactions with reported dissociation con-
stantsrangingfromthehighnanomolartothemid-micromolar
range (Supplementary Tables S1B and S3). We detected the
weak interactions taking place between the yeast tricalbin
Tcb3 and PtdInsPs at low calcium concentration (Schulz and
Creutz, 2004), interactions that were speciﬁcally enhanced by
the addition of calcium (data not shown).
Data ﬁltering and speciﬁcity of the lipid–array
assay
We considered several potential sources of false negatives and
false positives in the lipid–array assay (see Supplementary
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Figure 1 Identiﬁcation of protein–lipid interactions in S. cerevisiae using lipid–
arrays and live-cell imaging. (A) Charting protein–lipid interactions with lipid–
arrays. (B) Summary of the different lipids analyzed. Lipids are grouped according
to their metabolic pathways. Numbers of different lipids analyzed for each pathway
are indicated. (C) Summary ofthe differentproteins analyzed. Proteins aregrouped
according to their LBDs. For each category, the numbers of proteins analyzed are
indicated. (D) Summary of the validation procedure. The number of proteins
analyzed in each assay is represented. Asterisk points to the series of 29 proteins
that bound PtdInsPs (and not sphingolipids) and that we used as control.
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the nitrocellulose membranes, (ii) promiscuous lipids or
proteins and (iii) non-speciﬁc interactions solely due to the
TAP tag, to hydrophobic or electrostatic nature of some
proteins or lipids. Based on the ﬁrst two considerations, we
eliminated eight most water-soluble metabolites (ethanola-
mine phosphate, CDP-choline, CDP-ethanolamine, CoA, acetyl-
CoA, acetoacetyl-CoA, 3-OH-3methylglutaryl-CoA and L-serine)
that showed little or no binding to proteins, and might
have desorbed from the nitrocellulose membrane, and four
promiscuous lipids (phosphatidic acid, phosphatidylserine,
phosphatidylglycerol and desmosterol) that bound to 434% of
the proteins screened (Supplementary Figure S1). The cut-offs
were set to ensure best coverage of the literature-derived
reference data set (see below). Regarding the third possibility,
thelevelofexpressionofindividualTAPfusionswasnotfound
to correlate with lipid-binding frequencies (data not shown).
The set of proteins that bound lipids was not biased for
hydrophobic (Supplementary FigureS2) orabundant (Ghaem-
maghami et al, 2003) (data not shown; see Supplementary
information) proteins and binding frequency was not depen-
dent on lipid hydrophobicity or ionic state (Supplementary
Figure S1). Overall, this illustrates that the assay did not
produce general biases due to the presence of the TAP tag or
the hydrophobic or electrostatic nature of some proteins or
lipids. Rather, the binding proﬁles of related metabolites, such
as different intermediates in a metabolic pathway or the ﬁve
non-physiological analogs, revealed that discrete changes in
lipid head groups affected protein speciﬁcity (Supplementary
Figures S3 and S4). As might be expected, non-physiological
lipidanalogstendgenerallytobindtofewerproteinsthantheir
natural counterparts. Lipids with similar structures do tend to
share target proteins, but some discrete changes in lipid head
groups can confer distinct protein-binding speciﬁcities. For
example, for two metabolites of phosphatidylethanolamine,
phosphatidyl-N-methylethanolamine and phosphatidyl-N-di-
methylethanolamine, the presence of methyls in the head
group affected protein binding (Supplementary Figure S3A).
Similarly, we observed mutually exclusive binding for
dihydrosphingosine-1P (DHS-1P) and a non-physiological
analog unsaturated at position 4–5, sphingosine-1P (Supple-
mentary FigureS3B). Adouble bond at this position affects the
degree of freedom of the head group, likely accounting for the
different binding properties. Head group phosphorylation also
contributed to binding speciﬁcities of sphingolipids (Supple-
mentary Figure S3B) and PtdInsPs. Phosphorylation of the
latterat position three on the inositol ring conferreddistinctive
protein-binding proﬁles (Supplementary Figure S4) (Lemmon,
2008). Consistent with previous observations (Narayan and
Lemmon, 2006), this suggests that lipids arrayed on nitro-
cellulose membranes have their hydrophilic head groups
accessible for biomolecular interactions.
Assessment of overall data quality
After data ﬁltering (i.e. removal of the four promiscuous and
the eight most water-soluble lipids; see above), we obtained
530 interactions, among 124 proteins and 30 lipids (Figure 2;
Supplementary Table S2B). Among all lipids studied, PtdInsPs
were the most frequent binders (Figure 2; Supplementary
Figure S5): 79% of the lipid-regulated proteins and 58%
of the proteins with an LBD interacted with one or more
PtdInsPs. Proteins with an LBD generally bound lipids more
frequently: 66% were bound to more than one lipid. Proteins
with an LBD bound to a median of three lipids, whereas
unclassiﬁed proteins bound to one (P¼0.032; Supplementary
Figure S6).
We further assessed the quality of the data by comparing
the results with known protein–lipid interactions (Figure 3A).
We measured the false negative rate (fraction of true inter-
actions missed) by comparison with a set of 40 protein–lipid
interactions obtained from the literature and the STITCH
database (Kuhn et al, 2008) (Supplementary Table S3A and B).
The lipid–array data recovered 60% of this literature-derived
reference data set (P 0.000001). Missed interactions include
those requiring additional binding events unlikely to occur
in vitro. For example, in higher eukaryotes, the interaction
between C1 domains and diacylglycerol entails both deep
insertion of the domain in the membranes and the binding of
basic residues to phosphatidylserine head groups (Kazanietz
et al, 1995). For comparison, we also used a set of 31
interactions between enzymes or transporters in lipid meta-
bolism and their substrates or products. Only 29% of those
were captured, illustrating the method’s limited ability to
recover labile enzyme/substrate-binding events as well as
interactions that imply binding in the hydrophobic pocket of
lipid transfer proteins. We also compared with a published set
of interactions measured in yeast using proteome arrays and
PtdInsPs(Zhuetal,2001).Ofthe152proteinscommontoboth
analyses, 77 interacted with PtdInsPs in either data set, our
screenidentiﬁed76.ThestudyofZhuetalfoundﬁve,ofwhich
four were also found in our analysis (5.2% overlap). It is
important to emphasize that the Zhu et al data set (150 lipid-
binding proteins) recovers none of the interactions from the
literature-derived reference data set and that it is largely
devoidofinteractionsinvolvingLBDs.Instead,itisenrichedin
hydrophobic and often unknown proteins (Supplementary
Figure S2), suggesting that this different assay has captured an
interaction space different from that charted here.
A fraction of genetic networks are known to coincide with
physical interaction networks (Kelley and Ideker, 2005; Fraser
and Plotkin, 2007), a property we exploited as an estimate
of accuracy. From SGD (http://www.yeastgenome.org) and
the literature (Nash et al, 2007; Costanzo et al, 2010), we
assembled a list of 328 genetic interactions (for example,
synthetic or suppressive genetic interactions; Figure 3A)
between 96 enzymes involved in lipid metabolism and the
172 analyzed proteins (Supplementary Table S3C). We deﬁned
positive overlaps (between genetic and physical interactions)
as those in which a lipid from a physical protein–lipid
interaction resided inside a pathway containing one or more
genessharingageneticinteractionwiththeprotein(Figure3A;
see also Materials and methods; Supplementary information).
If the lipid–array and the literature-derived reference data sets
are comparable in terms of quality and biological relevance,
they should be similarly covered by genetic interactions
(Figure 3B). Using the genetic coverage of the literature-
derived reference data set, mainly implying PtdInsPs (Supple-
mentary Table S3A and B), we extrapolated the fraction of
true interactions (accuracy) across all lipid classes in our
Protein–lipid interactions network
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information). We found that the agreement between the
lipid–array and the genetic data sets is signiﬁcant (Po0.01).
In particular, the literature-derived reference data set and the
proteins interacting with PtdInsPs on the lipid–array show a
similar threefold (P¼0.015) and twofold (P¼0.035) enrich-
ment in genetically consistent interactions, respectively. This
is consistent with the view that the lipid–array interactions
were often functionally informative. Overall, the set of lipid–
array interactions shows similar quality in terms of false
positives and false negatives as those previously reported for
large protein–protein interaction sets (von Mering et al, 2002;
Tarassov et al, 2008).
Multiple validations of the protein–lipid data set
Todeterminewhether theprotein–lipidpairsmeasured invitro
could represent true interactions in vivo, we relatedthe in vitro
bindingproﬁlestophysiologicallyderivedinvivodata.Weﬁrst
integrated genetic interactions (see above); the lipid–array
data set provides a molecular hypothesis for 136 genetic
interactions previously identiﬁed (41% of the genetic data set;
Po0.01). This is considerably more than could be inferred
fromtheliterature-derivedreferencedatasetthatcontributeda
basis for only 14 interactions (4.2% of genetic data set). For 10
proteins (representing 34 protein–lipid pairs) selected because
they represented intriguing novelties or speciﬁcities, we used
more physiological assays (Table I): protein recruitment to
liposomal (Supplementary Figure S7A–E) and biological
(Supplementary Figure S7F and G) membranes. We could
verify 24 interactions involving eight proteins Ecm25, Ira2,
Slm1, Ypk1, Rvs161, Rvs167, Las17 and Pkh2 (Table I). For
example, we conﬁrmed the interaction initially observed
between Pkh2, a serine/threonine protein kinase required for
endocytosis,and PtdIns, PtdIns(4)Pand PtdIns(4,5)P2, but not
PtdIns(3)P (Supplementary Figure S7A). Pkh2 recruitment to
liposomal and biological membranes requires speciﬁc
PtdInsPs and involves a predicted globular domain at the C-
terminus of Pkh2 that might act as a new type of LBD. For one
lipid, PtdIns(4,5)P2, speciﬁcity was further assessed. Speciﬁ-
cally, the soluble analog of PtdIns(4,5)P2, inositol(1,4,5)P3,
inhibited binding of the C-terminal domain of Pkh2 to
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Figure 2 Protein–lipid map in yeast. The table displays all interactions color coded according to the number of experimental supports: reproducibility with proteins
expressed in homologous and heterologous systems, binding to artiﬁcial (liposome) and biological (live-cell imaging) membranes and genetic interactions. The data set
is provided as Supplementary information (Supplementary Tables S2C and S4; see also Supplementary Data 1). The bar charts show the fraction of novel interactions
per lipid or protein classes for which supporting evidence is available. The total numbers of novel interactions are displayed next to each bar. The pie charts represent
the fraction of conserved proteins. PtdInsP, phosphatidylinostitol phosphate; GPL, glycerophospholipid; SL, sphingolipid; FA, fatty acid; GL, glycerolipid; S&P, sterol
and prenol.
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human homolog of Pkh2, the kinase PDK1, a C-terminal PH
domain fulﬁlls a similar binding function. We also conﬁrmed
the selective binding of Las17, a member of the WASP/WAVE
familythatregulatestheArp2/3complexandactinfunction,to
PtdIns(3,5)P2 and PtdIns(3,4,5)P3 (a non-physiological analog
in yeast), and not PtdIns(4,5)P2 (Supplementary Figure S7B).
In human, similar binding proﬁles have been reported for
WAVE2, another member of the WASP/WAVE family (Oikawa
et al, 2004), illustrating the conservation of lipid binding
across considerable evolutionary distances. As a substantial
fraction (45%) of the analyzed proteins were conserved in
humans (Figure 2), the protein–lipid data set will have
functional implications for higher eukaryotes and thus for
human biology.
We integrated the validations in a scoring system that ranks
all interactions by considering the number of experimental
supporting observations (Figure 2). This also included further
validation of the selected set of 49 proteins that bound
sphingolipids (see below). Overall, 54% of interactions were
supported by additional evidence (Supplementary Tables S2C
and S4; see also Supplementary Data 1).
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Overall, 68% of all interactions were novel (i.e. absent from
the literature-derived reference) or unexpected from either
protein sequences or known LBDs speciﬁcities (Figure 2). For
example, we found Ecm25, a RhoGAP of unknown function,
associated to several different lipids, with a binding proﬁle
usually indicative of the presence of an LBD (Supplementary
Figure S6; Supplementary Table S2B). Using sequence
searches for remote homologs of known LBDs, we found that
Ecm25 has a cryptic CRAL/TRIO domain that was previously
undetected (Figure 4; see Materials and methods; Supplemen-
tary information). Another example is the RasGAP Ira2. The
partial structure of the human ortholog, the tumor suppressor
neuroﬁbromatosis type 1, revealed the presence of an
unexpected bipartite lipid-binding module that consists of
both a CRAL/TRIO (Sec14) and a PH-like domains (D’Angelo
et al, 2006). Our observation of Ira2 binding to PtdInsPs
(Supplementary Table S2B) is consistent with a structure-
based alignment that reveals that the CRAL/TRIO and PH-like
domainsareprobablyconservedin Ira2(D’Angelo et al, 2006).
These predictions were further tested in a more physiological
assaymeasuringproteinrecruitmenttoliposomalmembranes.
Using recombinant, puriﬁed domains, we could conﬁrm that
the cryptic Ecm25-CRAL/TRIO and the Ira2-CRAL/TRIO/PH
domains alone are responsible for lipid binding (Figure 4B;
Table I; see also Supplementary Figure S7C). This illustrates
that some LBDs have only weak sequence similarity to
canonical examples found in databases like SMART (Letunic
et al, 2006) or Pfam (Finn et al, 2008). Their annotation
requires supporting biochemical measurements such as those
in the data set presented here. This extended repertoire of
protein–lipid interactions can be used as the basis for more
detailed mechanistic or structural studies.
New effectors of sphingolipids signaling validated
in vivo by live-cell imaging
We extended the biological validation in vivo to the set of
proteins that bound sphingolipids, a class of bioactive lipids
that play important signaling functions in yeast and higher
eukaryotes. The exact mode of action for these lipids remains
elusive (Hannun and Obeid, 2008) and the data set points to
series of new cellular targets. We identiﬁed 63 proteins that
interacted with sphingoid long-chain bases (LCBs), ceramides
or phosphorylated LCBs (Figure 5; Supplementary Table S5).
These proteins included the ﬁve previously known sphin-
golipid effectors in yeast: the LCBs-responsive kinases Pkh1/
Pkh2 and Ypk1/Ypk2 (Friant et al, 2001; Liu et al, 2005)
(orthologs of the human PDK1 and SGK, respectively) that we
found associated with LCBs or phosphorylated LCBs, as well
as phospholipase D (Spo14), a known target of sphingolipids
in mammals (Abousalham et al, 1997). The cellular functions
of theproteinstargetedbysphingolipids included endocytosis,
cell polarity and lipid metabolism (Figure 5).
Using live-cell imaging, we determined the effect of
perturbation of sphingolipid metabolism with the antibiotic
myriocin on the cellular localization of 49 candidate sphingo-
lipid targets fused to GFP. The speciﬁcity of the myriocin
effect was assessed by the addition of a metabolite (DHS)
that bypasses its inhibitory effect and restores sphingolipid
synthesis (Figure 5A). As controls, we used a series of 29
proteins that bound PtdInsPs only, as well as three other
proteins localized to the membrane and cell cortex (Figure 5B;
Supplementary Figure S8A). We quantiﬁed the effects of
myriocin using a standardized method for 32 proteins that
showed similar punctate localization patterns (Supplementary
Figure S8B; see Supplementary information). For the remain-
ing49 GFPfusions that hadmore diverselocalizationpatterns,
we assessed the effects qualitatively (Supplementary Table
S6). Importantly, interactions induced upon cell stimulation or
stress, as well as those that might affect protein properties
other than localization (e.g. activity), are not traceable in this
assay. Nevertheless, proteins that bound sphingolipids in vitro
were nearly four times more frequently sensitive to myriocin
treatment than the set of controls (Po0.009; Figure 5) and the
effect of myriocin was not mimicked by the inhibition of the
known effectors of sphingolipid in yeast, the Pkh1/Pkh2
pathway (Supplementary Figure S7G). Overall, this is con-
sistent with proteins that bound sphingolipids in vitro also
being direct sphingolipid targets in vivo.
Examples involving proteins conserved in higher eukar-
yotes were frequent (Figure 2). The two actin-associated
proteins, Rvs161 and Rvs167, homolog of the mammalian
Table I Summary of protein–lipid interactions selected for validation
Protein
name
Lipid Validation
assay
Ecm25 PtdIns Liposomes
Ecm25 PtdIns(3,4,5)P3 Liposomes
Ira2 PtdIns(3,4,5)P3 Liposomes
Las17 PtdIns(3,5)P2 Liposomes/mss4
ts
Las17 PtdIns(3,4,5)P3 Liposomes
Pkh2 PtdIns Liposomes
Pkh2 PtdIns(4)P Liposomes/mss4
ts
Pkh2 PtdIns(3,4)P2 Liposomes
Pkh2 PtdIns(3,5)P2 Liposomes/mss4
ts
Pkh2 PtdIns(4,5)P2 Liposomes/mss4
ts
Slm1 PtdIns(4,5)P2 Liposomes/mss4
ts
Rvs167 PtdIns(4,5)P2 Liposomes/mss4
ts
Slm1 DHS-1P Liposomes/myriocin Pkh1/2
independent
Rvs167 DHS-1P Liposomes/myriocin Pkh1/2
independent
Slm1 PtdIns(4)P mss4
ts
Rvs167 PtdIns(4)P mss4
ts
Rvs161 PtdIns(3)P mss4
ts
Ypk1 PtdIns(4)P,
PtdIns(4,5)P2
mss4
ts
Ecm25
a PHS-1P, Sph, Sph-1P Myriocin
Las17 PHS-1P, Sph-1P Myriocin Pkh1/2
independent
Mss4
a DHS-1P Myriocin Pkh1/2
dependent
Rvs167 PHS-1P Myriocin Pkh1/2
independent
Ypk1 DHCer, PHCer-C18 Myriocin Pkh1/2
independent
Spo14
a PHS, Sph, DHCer,
PHCer-C8,
PHCer-C18, Cer
Myriocin
aProtein–lipid interactions that could not be conﬁrmed.
Liposomes, bindingto liposomes; mss4
ts, perturbation of cellular PtdInsPsusing
anmss4
tsmutant;myriocin,perturbationofcellularsphingolipidsusingmyriocin.
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cytosis. They both possess a Bin/Amphiphysin/Rvs-homology
domain that generates and senses membrane curvature by
binding negatively charged lipid head groups (Lemmon,
2008). In vitro, we found Rvs167 associated with PtdInsPs
and phosphorylated LCBs; interactions that were conﬁrmed
using artiﬁcial membranes (Supplementary Figure S7D).
Consistent with these interactions having a role in vivo,
inhibition of either PtdInsPs or sphingolipid synthesis speci-
ﬁcally perturbed Rvs161 and Rvs167 association with punctate
structures at the plasma membrane (Figure 5A; Supplemen-
tary Figure S7F and G). Protein levels were unaffected by
the treatments (data not shown). These results provide a
molecular explanation for several genetic interactions pre-
viously reported between amphiphysins and enzymes in
sphingolipid metabolism (Desfarges et al, 1993) and support
a direct targeting role of sphingolipids in endocytosis that
might be conserved in higher eukaryotes.
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Figure 4 Identiﬁcation of a new cryptic lipid-binding domain in Ecm25. (A) Structure-based alignment of Ecm25 and ﬁve known CRAL/TRIO domain. Conserved
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(PS), PtdIns or PtdIns(3,4,5)P3, as indicated (3%, molar). Ecm25-CRAL/TRIO was analyzed by western blot.
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Despite the importance of sphingolipids in signaling pro-
cesses, only a few domains, such as START or Saposins,
have been reported to speciﬁcally bind these lipids in higher
eukaryotes, and none of them have been found in yeast.
Interestingly, almost 60% of proteins binding to phos-
phorylated LCBs in our assay also contained a PH domain
and bound PtdInsPs (Figure 6A). Overall, 18 proteins with
PH domains, out of the 29 that bound lipids on the
array, bound phosphorylated PtdInsPs and LCBs (Figure 6B).
These associations to phosphorylated LCB were often physio-
logical; the proteins that bound both PtdInsPs and phos-
phorylated LCB were four times more sensitive to myriocin
treatment than those that bound only PtdInsPs (42 versus
10%; Po0.02). This suggests that some PH domains might
have unanticipated ligands and also have a function in
sphingolipid recognition.
To test this hypothesis further in more physiological assays,
that is the binding to artiﬁcial membranes in vitro and to
cellular membranes in vivo, we selected two PH domains with
different speciﬁcities: that from Slm1 (Slm1-PH), a component
of the TORC2 signaling pathway (Fadri et al, 2005) that bound
bothDHS-1PandPtdInsPs(SupplementaryTableS2B),andthe
more prototypic PH domain of PLCd (PLCd-PH) known to
recognize PtdIns(4,5)P2 (Lemmon et al, 1995). As expected
from its known speciﬁcity, the efﬁcient recruitment of the
PLCd-PH to both artiﬁcial (Kd¼0.2mM; Figure 6C and D; see
also Supplementary Figure S9) and biological (Figure 6E;
Supplementary Figure S8C) membranes required only
PtdIns(4,5)P2. In contrast, Slm1-PH showed an unusual
behavior. Its targeting to liposomal membranes depends on
the speciﬁc presence of both PtdIns(4,5)P2 and DHS-1P
(Kd¼1.8mM; Figure 6C and D; see also Supplementary Figure
S9). Other similar, negatively charged lipids, such as phos-
phatidylserine, have no effect illustrating speciﬁcity for
DHS-1P (Supplementary Figure S7E). Finally, in vivo, both
PtdIns(4,5)P2 and sphingolipid metabolisms are required for
Slm1 association with speciﬁc membrane microdomains, the
eisomomes (Figure 6E; Supplementary Figure S8D; Supple-
mentary Movies S1 and S2). Other Slm1 locations such as
its assembly in very dynamic membrane domains, distinct
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Figure 5 Lipid–arrays and live-cell imaging identify new series of sphingolipid effectors. (A) The effect of the perturbation of sphingolipid metabolism on GFP-fusion
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perturbations (Supplementary Movies S1 and S2).
Overall, the observations above suggest cooperative lipid-
binding by Slm1-PH. Consistent with these observations, the
structure of Slm1-PH, which we solved by X-ray crystal-
lography at 2A ˚ resolution, suggests the presence of an
additional positively charged cavity in Slm1-PH (Figure 7A;
Supplementary Table S7). The two putative Slm1-PH-binding
pockets considerably vary in size. Manual docking with
DHS-1P and PtdIns(4,5)P2 supports the view that the two
lipids with head groups of different sizes (PtdIns(4,5)P2 is
substantially bigger than DHS-1P) can simultaneously bind
Slm1-PH. Interestingly, the aliphatic chains of the two lipids
point toward two conserved hydrophobic residues (F481 and
L482), surprisingly exposed in the loop that separates the
two putative binding sites. We also identiﬁed two positively
charged residues, often conserved among PH domains that
point to the canonical binding site in PLCd-PH (Figure 7A
and B; Supplementary Figure S10) and were found to each
contributetooneputativebindingsite inSlm1-PH (Figure7A).
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positive charges in each predicted Slm1-PH-binding site and
speciﬁcally destabilizes the membrane association of Slm1
with the eisosome (Figure 7C). These point mutations also
cause signiﬁcant (Po0.01) cumulative defects in Slm1 func-
tion: yeast growth and actin polarization (Figure 7D). The
stronger and apparently additive defect of the double mutant
suggest that both positively charged sites are required for
proper Slm1 functioning.
Collectively, these results indicate that the PH domain of
Slm1 might work as a coincidence sensor to integrate both
PtdInsP and sphingolipid signaling pathways. It might
contribute to the cross-talk between the signaling of these
two lipids that has been previously inferred based on genetic
interactions in yeast (Tabuchi et al, 2006). Although the
structuralandmechanisticdetailsfor thisbindingremaintobe
fullycharacterized, recent structuraldatasimilarlysupportthe
existence of a second, non-canonical binding site in certain PH
domains (Ceccarelli et al, 2007). Our results also reinforce the
emerging notion that cooperative mechanisms have important
functions in PH domains functioning (Maffucci and Falasca,
2001).ThesemechanismsinitiallydescribedbetweenPtdInsPs
and proteins can now be extended to new lipid classes,
illustrating the beneﬁt of unbiased and systematic analyses.
Lipid-binding proﬁles as predictor for protein
recruitment to biological membranes
Having shown the accuracy and in vivo relevance of the
detected lipid-binding proﬁles, we sought to use this infor-
mation as a ﬁngerprint for predicting other protein proper-
ties such as protein localization. In the past, pioneering
attempts to use PtdInsP-binding proﬁles for predicting
membrane targeting or sub-cellular localization had limited
success (Yu et al, 2004; Park et al, 2008). While PtdInsP-
binding certainly has an important function, targeting to
biological membranes in vivo also requires additional, often C
Pil1-RFP
6 min 6 min 6 min
W.T.
R477A
R478A
R478A
R477A
Slm1-GFP Merged
3
7
°
C
-
Δ
s
l
m
2
Growth
R
4
7
7
A
R
4
7
8
A
M
y
r
i
o
c
i
n
B
l
a
n
k
R
4
7
8
A
R
4
7
7
A
2
5
°
C
-
Δ
s
l
m
2
D
W
.
T
.
W
.
T
.
R
4
7
7
A
R
4
7
8
A
R
4
7
8
A
R
4
7
7
A
Actin polarization
(Heat-Δslm2) 
P
o
l
a
r
i
z
e
d
 
c
e
l
l
s
 
(
%
)
0
60
20
40
*
W
.
T
.
R
4
7
7
A
R
4
7
8
A
R
4
7
8
A
R
4
7
7
A
25°C 37°C
A Slm1-PH
R477
R478
K30
K32
90°
PLC  -PH
30
480
Slm1-PH EKGLR K
LG Q L K S
470
IS F E S RF
LK S L S VK
B
PLC  -PH
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PH with that of PLCd-PH (Protein Data Bank (PDB) entry 1mai). The two
structures arerepresented inthe sameorientations. PLCd-PHbinds lipidwithin a
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the presence of myriocin; lower panels during heat stress. The bar chart
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mutants is signiﬁcant compared with wild-type (Po0.01), R477A (Po0.01)
and R478A (Po0.01) single mutants. The mutations have no effect on Slm1
expression levels (western blot not shown).
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(Maffucci and Falasca, 2001) that might have been captured
with the screen (see above).
We grouped proteins by ﬁrst scoring the similarity between
pairs of lipid-binding proﬁles using a metric that considers
both lipid and protein promiscuity, and used these scores for
complete linkage clustering. Proteins sharing similar lipid-
binding proﬁles also showed a tendency to share attributes,
such as the presence of PH domains or localization in punctate
structures in membranes (Figure 8A). These include the
phosphatidylinositol-4-phosphate 5-kinase Mss4, known to
localize in the cytoplasm and the membrane (Huh et al, 2003).
The Mss4-binding proﬁle clustered with proteins localized in
dotted structures, an observation we could conﬁrm by high
resolution live-cell imaging (Figure 8B) (Sun et al, 2007).
Another example is a cluster of proteins that show similar
localization at the yeast bud, all of which were also insensitive
to myriocin treatment. This illustrates the promise for compre-
hensive lipid-binding proﬁles to contribute to the molecular
rationale for protein localization or dynamic behavior at
biological membranes.
Discussion
Accurate representations of biological processes require
systematic charting of the physical and functional links
between all cellular components. There is a clear need to
expand the current biomolecular networks beyond protein–
protein or protein–nucleic acid interactions, and involve
additional biomolecules. It is important to widen bottlenecks
in biochemical characterization by large-scale approaches.
This work shows the feasibility and beneﬁts of large-scale
analyses combining biochemical arrays and live-cell imaging
for charting protein–lipid interactions.
The number of novel interactions discovered clearly shows
that even major classes of metabolites, such as PtdInsPs and
sphingolipids, have been insufﬁciently studied, calling for
further system-wide analyses. Many of the binding events
reportedcouldnotbeinferredfromsequencecomparisonand/
or the presence of canonical LBDs, arguing that the sites and
modalities of protein–lipid recognition are still largely elusive.
Even for known LBDs, our data suggest additional binding to
new ligands. The observation that some PH domains might
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pathways involving sphingolipids adds to the view that PH
domains can recognize other ligands besides PtdInsPs (Lemmon,
2004).Indeed,only10%ofthe234humanPHdomain-containing
proteins show strong and speciﬁc binding to PtdInsPs (Lemmon,
2008). Our data supports the notion that binding to several
different lipids could well represent an attribute shared by
other LBDs. Integration of different signals would ensure
efﬁcient, but also regulated targetingtobiological membranes.
Overall, the study has shown the importance of extending
molecular interaction space from proteome- to metabolome-
wide efforts and of systematic classiﬁcations of bioactive
molecules based on their binding proﬁles. The data provided
here represents an excellent resource to enhance the under-
standing of lipids function in eukaryotic systems.
Materials and methods
Lipid–arrays
The protocol to produce lipid–arrays was developed from Kanter et al
(2006). Brieﬂy, 1mM solutions of lipids were prepared in adequate
solvent mixtures. Using an argon ﬂow, 0.1ml of each lipid was sprayed
on a nitrocellulose membrane (Hybond-C Extra, GE Healthcare) with
an ATS4S spotter (CAMAG). We also spotted a nitrobenzoxadiazole-
labeled phosphatidylglycerol (Sigma) at different positions on the
array and monitored the quality of the spotting procedure by scanning
at 432nm excitation (GenePix 4000B, Molecular Devices). The three
different solvent mixtures used (chloroform, chloroform:methanol 1:1
and chloroform:methanol:water–HCl 1:1:0.2) were also sprayed as
blank controls. All the samples were spotted in duplicate. The arrays
were stored at 41C under argon atmosphere and protected from light.
Lipid overlay assay
The S. cerevisiae strains expressing the desired TAP-tagged protein
were grown at 301Ct oa nO D 600 of 3.5–3.8. Pelleted cells were
disrupted by glass beads beating. Cell extracts were obtained by a
30min centrifugation at 22000r.p.m. at 41C and ﬁltration (HPF
Millex
s—0.45mm). The lipid overlay assay was adapted from Dowler
et al (2000). The arrays were blocked for 1h in 2ml of blocking buffer
(3% fatty-acid-free BSA, 150mM NaCl, 10mM Tris pH 7.4). The arrays
werethenincubatedfor1hinthepresenceofcellextracts,washedand
the bound TAP-tagged proteins were immunodetected with PAP or
with V5-speciﬁc antibodies (Invitrogen).
Molecular biology and recombinant protein
expression
All primers used are listed in Supplementary Table S8. TAP-tagged
proteinsselectedforrecombinantexpressioninE. coli(Supplementary
Tables S1B and S2A) and the PH domain of Slm1 (Slm1-PH) were
cloned in pET100-D/TOPO or pET101-D/TOPO vector (Invitrogen)
following the manufacturer’s instructions. Mutations in Slm1 were
introduced using the QuikChange
s lightning Site-Directed Muta-
genesis kit (Stratagene). For detailed information on the cloning,
mutagenesis, expression and puriﬁcation of the recombinant proteins,
as well as strains used in this study, see Supplementary information.
Live-cell imaging
Perturbation of sphingolipid metabolism with myriocin
The localization of endogenously expressed proteins was examined
using yeast strains expressing GFP fusions (Huh et al, 2003). Cells
attached on 35mm glass bottom culture dishes coated with
Concanavalin A were treated with 5mM myriocin or 5mM myriocin
and 5mM DHS(Sigma). The effect of myriocin was measured after 2h
treatment, which represents the minimal exposure time that induced,
in our experimental setting, the delocalization of two proteins that
bound sphingolipids in vitro: Mss4 and Slm1. Under these conditions,
cells remained perfectly viable (data not shown) and other membrane
residentwere unaffected(Figure6E; Supplementary Figure S8A). Fora
more detailed description of the procedure, see Supplementary
information.
Imaging was performed with an Olympus IX81 microscope
equipped with 100 /NA 1.45 objective lens and Hamamatsu
Orca-ER camera.
For 49 GFP fusions that did not localize in punctate structures,
the effect of myriocin was assessed qualitatively. Those proteins
were considered sensitive to myriocin if the effect was restored
by DHS. Yhr131c did not fulﬁll this requirement. We quantiﬁed the
effects of myriocin using a standardized method for 32 proteins that
showed similar punctate localization patterns (see Supplementary
information).
Perturbation of PtdIns(4,5)P2 metabolism
The mss4
ts cells coding for the respective C-terminal GFP-tagged
proteinwere grown and attachedto dishes at 251C, following the same
protocoldescribedabove.Disheswerekeptattheselectedtemperature
(25 or 371C) for 2h and imaged immediately after. Same protocol was
followed for PLCd-PH-GFP. In this case, mss4
ts strain was transformed
with the plasmid coding for PLCd-PH-GFP.
Perturbation of Pkh1/Pkh2 signaling pathway
The pkh1
ts/Dpkh2 cells coding for the respective C-terminal GFP-
tagged proteins were grown and attached to dishes at 251C, following
the same protocol described above. Dishes were kept at the selected
temperature (25 or 371C) for 1h and imaged immediately after. At
371C, pkh1
ts/Dpkh2 cells are defective in actin polarization (Inagaki
et al, 1999). One hour represents the ﬁrst time point, in our
experimental condition, in which we observed the delocalization of
theactin-bindingproteinAbp1.Undertheseconditions,cellsremained
viable (data not shown).
Cell based assays to assess Slm1-PH function
Actin polarization assay was performed as previously described (Fadri
etal,2005;seeSupplementaryinformation).Yeastwild-typestrainand
strains carrying point mutations in Slm1-PH domain were grown on
SC plates containing 500ngml
–1 myriocin or equivalent amounts of
methanol at 301C for 3 days. Strains carrying Slm2 deletion (Dslm2)
were grown in YPD plates at 25 or 371C for 1 day.
Liposome preparation
A mixture of the lipids was prepared in chloroform:methanol:water,
1:1:0.07, containing 0.03% HCl. We added 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (Avanti Polar Lipids) to a ﬁnal concentra-
tion of 3.8mM. Where indicated, PtdIns, PtdIns(3)P, PtdIns(4)P,
PtdIns(5)P,PtdIns(3,4)P2,PtdIns(3,5)P2,PtdIns(4,5)P 2,PtdIns(3,4,5)P3,
DHS-1P(AvantiPolar Lipids) andphosphatidylserine(Sigma)werealso
included.Lipidmixturesweredriedunderanargonstreamfollowedby
30minhighvacuum.Driedmixtureswererehydratedinbindingbuffer
(10mMHEPES,150mMNaCl,pH7.4)bymixingat601Cfor2h.Lipids
were subjected to 5min sonication and three snap-freeze/thaw cycles
in liquid N2 and shaking at 601C. Finally, small unilamellar vesicles
were generated using a mini-extruder (Avanti Polar Lipids) and a
membrane pore size of 0.1mm.
Liposome-binding assays: ﬂotation assay and size
exclusion chromatography and western blot
Flotation assay was performed as previously described (Miller et al,
2002) (see Supplementary information). Size exclusion chromatography
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10/30 column, equilibrated with binding buffer at the ﬂow rate
0.25ml min
 1. After 30min incubation at 221C with 8mM Slm1-PH
or PLCd-PH, 250ml of the different liposome solutions were injected.
We collected 0.5ml fractions that were then analyzed by SDS–PAGE
andwesternblot.AV5-speciﬁcantibodyproducedinmouse(Invitrogen)
was used to detect Slm1-PH. Total band intensity was integrated with
Photoshop software and normalized versus the total amount of protein
loaded. Presented resultsare thesum of all detected fractions of Slm1-PH
or PLCd-PH co-eluted with liposomes.
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) was performed using a VP-ITC
Microcal calorimeter (Microcal). Injectant (Slm1-PH or PLCd-PH) was
dialyzed extensively against binding buffer before all titrations. The
experiments were performed at 251C. A typical titration consisted of
injecting 6–12ml aliquots of 47mM protein into the different solutions
of liposomes, at intervals of 5min to ensure that the titration peak
returned to the baseline. The ITC data were corrected for the injectant
dilution heat. To estimate Kd, we used the concentration of binding
sites on liposome surface as a ﬁtting parameter, assuming that the
interactions occur in a stoichiometry of 1:1. The analysis was
performed with the Origin 5.0 software.
Slm1-PH crystallization and structure
determination
Crystals were grown at 201C by vapor diffusion using the sitting-drop
method. For crystallization, 0.5ml of protein solution (9mgml
–1) were
mixedwith0.5mlofprecipitantsolution(2M(NH4)2SO4,2% PEG400,
0.1M Hepes pH 7.5). A single crystal was cryo-protected in mother
liquor supplemented with 30% glycerol and ﬂash frozen in liquid
nitrogen at100K. Diffraction datawere collectedat beamlineID14-2of
the European Synchrotron Radiation Facility (ESRF, Grenoble France)
using an ADSC Q4r CCD detector, and subsequently processed with
XDS (Kabsch, 2010). The structure was solved by molecular replace-
ment with the program PHASER (McCoy et al, 2007) using a search
model obtained from the PDB entry 1btk (Hyvonen and Saraste, 1997)
after conversion to polyalanine and removal of poorly conserved
regions among PH domains. The search model included the following
residues in the PDB entry 1btk: 5–14, 25–42, 53–57, 63–65, 101–104, 111–
134. The initial solution was completed by iterative cycles of manual
building in COOT (Emsley and Cowtan, 2004) and reﬁnement using
PHENIX (Adams et al, 2002),yielding a ﬁnal modelwithRand Rfreevalues
of 22.1 and 27.1, respectively (Supplementary Table S7). The stereo-
chemistry of the ﬁnal model was checked with PROCHECK (Laskowski
et al, 1993). The atomic coordinates and structure factors have been
deposited in the Protein Data Bank under accession code 3nsu.
In Figure 7, the electrostatic potential calculated with APBS (Baker
et al, 2001) is represented on the solvent-accessible surface. Blue and
red indicate positive (þ4kT/e) and negative ( 4kT/e) potential,
respectively. Images were generated using Pymol (DeLano, 2002).
Estimation of accuracy based on interactions with
PtdInsPs pathway
We thought to use the genetic coverage of the literature-derived
reference data set to extrapolate the fraction of true interactions
(accuracy) in our data (see below). We reasoned that if the lipid–array
andtheliterature-derivedreferencedatasetarecomparableintermsof
quality and biological relevance, they should be similarly covered by
geneticinteractions.Astheliterature-derivedreferencedatasetmainly
consists of PtdInsPs, we used accuracy measured for this lipid class as
anapproximationfortheentiredataset.Forthisanalysis,intermediate
cutoff was used for Costanzo et al (2010) data set along with data
from SGD and literature (Supplementary Tables S2C and S4; see also
Supplementary Data 1).
Fordifferentsetsofproteins,wemeasuredthefractionthatinteracts
genetically withenzymesinvolvedinthesynthesis of PtdInsPs (Figure 3B):
(i)proteinsthatboundPtdInsPsintheliterature-derivedreferencedata
set (10/16¼62.5%¼reference genetic coverage); (ii) proteins that
bound PtdInsPs in the lipid–array (40/86¼46.5%¼experimental
genetic coverage); (iii) a set of proteins deﬁned as those proteins
devoid of LBD and that did not bind PtdInsPs in the lipid–array
(4/19¼21.1%¼background genetic coverage). We observed that the
literature-derived reference data set has signiﬁcantly more genetic
interactions than the background genetic coverage (P¼0.015). The
same was true for proteins that bound PtdInsPs in the lipid–array
versus the background genetic coverage (P¼0.035). Interestingly, the
lipid–array data did not show any signiﬁcant difference when
compared with the literature-derived reference data set (P¼0.18).
Fisher’s exact test was used to measure signiﬁcance.
We can now interpolate the fraction of true interactions (accuracy)
expected in the PtdInsPs lipid–array data set. The coverage of genetic
interactions in our data set results from two different components:
interactions of ‘true positive’ (x) and ‘false positive’ (1 x) proteins.
Assuming that the ‘false positive’ will have a genetic coverage equal to
the background genetic coverage and that ‘true positive’ will have a
genetic coverage equal to the reference genetic coverage, we predict
that 61.4% of the proteins are ‘true positives’ (see below). If all of the
86 proteins that bound PtdInsPs in the lipid–array are equally likely to
be among the ‘true positives’, the ‘true positive’ rate among our
protein–lipid interactions will also be 61.4% (Figure 3B).
GCExp ¼w   GCRef þð 1   wÞ GCBG ! 40=86
¼w   10=16 þð 1   wÞ 4=19 ! w ¼ 61:4%
where
w¼‘true positive’ in the lipid–array data set (accuracy).
(1 w)¼‘false positive’ in the lipid–array data set.
GCExp¼experimental genetic coverage.
GCRef¼reference genetic coverage.
GCBG¼background genetic coverage.
Prediction of a CRAL/TRIO in Ecm25
The putative CRAL/TRIO domain of Ecm25 was detected by running
HHsearch (Soding, 2005) for all yeast proteins against the SCOP 1.69
database.Fordetailedinformationonthesequence-basedalignmentof
the non-redundant set of structures annotated by Pfam as having a
CRAL/TRIO domain, see Supplementary information.
Clustering of proteins and lipids according to their
binding proﬁles
For every protein, we calculated the fraction f1 of all the lipids with
which it interacted and the fraction f0 of all the lipids with which it did
not interact. Likewise, for every lipid, we calculated the fraction f1o f
all the proteins with which it interacted and the fraction f0 of all the
proteins with which it did not interact. Then at every position (i, j)i n
the interaction matrix, we have a score s1i,j for an interaction between
protein i and lipid j¼log(f1i)þlog(f1j), and a score s0i,j for no
interaction¼log(f0i)þlog(f0j). Thus, an interaction between a pro-
miscuous protein and a promiscuous lipid has a lower score than an
interaction between a highly selective protein and lipid. We then
scored the similarity between the lipid-binding proﬁles of all pairs of
proteins i1 and i2 bysumming the scores for every lipid j in the proﬁle,
where the score for lipid j¼
s1i1,j þ s1i2,j when both proteins interact with lipid j
s0i1,jþs0i2,j when neither protein interacts with lipid j
 (s1i1,jþs0i2,j) protein i1 interacts with lipid j, but protein i2
does not
 (s0i1,jþs1i2,j) protein i1 does not interact with lipid j, but
protein i2 does
We then clustered the proteins by complete linkage using the
program OC (Barton, 2002), on the basis of these scores. We followed
the same procedure to cluster the lipids on the basis of their protein-
binding proﬁles. The calculation of the binomial probability for a
signiﬁcant deﬁciency or enrichment with a particular attribute and
correction for testing for a particular feature in multiple places is
described in Supplementary information.
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multiple sequence alignment), see Supplementary information.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (http://www.nature.com/msb).
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